Cannabis Bioscience International Holdings, Inc. (CBIH) EBT (2022 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted EBT of -$104035.0 for Q1 2026, up 8.53% sequentially from -$113737.0 in Q4 2025, and up 31.42% YoY from -$79160.0 in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) EBT (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported EBT for 5 years, with the latest figure at -$104035.0 in Q1 2026.
- Quarterly EBT rose 31.42% year-over-year to -$104035.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$699980.0 (down 81.97% YoY) and the FY2025 annual result came in at -$557627.0, up 12.92% from the prior year.
- EBT climbed to -$104035.0 in Q1 2026 per CBIH's latest filing, from -$113737.0 in the prior quarter.
- Over five years, EBT peaked at -$64202.0 in Q2 2024 and troughed at -$324655.0 in Q1 2023.
- A 5-year average of -$173299.4 and a median of -$166748.0 in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2024 and 2025: EBT soared 77.2% in 2024, then tumbled 322.36% in 2025.
- Over 5 years, EBT stood at -$219886.0 in 2022, then surged by 43.41% to -$124428.0 in 2023, then jumped by 45.09% to -$68328.0 in 2024, then slumped by 66.46% to -$113737.0 in 2025, then rose by 8.53% to -$104035.0 in 2026.
- According to Business Quant data, EBT over the past three periods registered -$104035.0, -$113737.0, and -$211046.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -104,035.00 |
| Nov 30, 2025 | -113,737.00 |
| Aug 31, 2025 | -211,046.00 |
| May 31, 2025 | -271,162.00 |
| Feb 28, 2025 | -151,707.00 |
| Nov 30, 2024 | -68,328.00 |
| Aug 31, 2024 | -100,421.00 |
| May 31, 2024 | -64,202.00 |
| Feb 29, 2024 | -209,192.00 |
| Nov 30, 2023 | -124,428.00 |
| Aug 31, 2023 | -181,789.00 |
| May 31, 2023 | -281,603.00 |
| Feb 28, 2023 | -324,655.00 |
| Nov 30, 2022 | -219,886.00 |